Andrew Cameron

Andrew Cameron has a diverse work experience in the pharmaceutical and biotechnology industry. Andrew is currently working at Voyager Therapeutics, Inc. as the Senior Director of Portfolio and Partner Management. Previously, they held the positions of Director of R&D Operations and Associate Director of R&D Operations at the same company. Prior to that, Andrew worked at Biogen as a Sr. Business Analyst II and Senior Associate Scientist. Andrew also worked at Pfizer as a Sr. Associate Scientist, focusing on identifying vascular targets for the treatment of CNS disorders. Additionally, they worked at EMD Serono, Inc. as an Associate Scientist, specializing in neurodegenerative research. Andrew's early career includes a role as a Research Associate at Massachusetts General Hospital, where they focused on Alzheimer's disease research.

Andrew Cameron completed their Bachelor's degree in Biology/Biological Sciences, General at Ithaca College. Andrew then went on to pursue a Master of Business Administration (MBA) at the Questrom School of Business, Boston University from 2017 to 2020. Andrew also obtained additional certifications, including a Lean Six Sigma Green Belt Certification from Questrom School of Business, Boston University in August 2020, and a Professional Scrum Master I certification from Scrum.org in June 2020.